Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults; [Análisis de costes y de coste/eficacia de las pautas recomendadas por GESIDA/Plan Nacional so

ANTONIO RIVERO ROMÁN2026-01-292026-01-29201810.1016/j.eimc.2017.04.0022-s2.0-85019937378https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/28129Infectious DiseasesMicrobiologyMicrobiology (medical)Infectious DiseasesMicrobiologyMicrobiology (medical)Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults; [Análisis de costes y de coste/eficacia de las pautas recomendadas por GESIDA/Plan Nacional soresearch article